1. Home
  2. KLXE vs XLO Comparison

KLXE vs XLO Comparison

Compare KLXE & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

N/A

Current Price

$2.81

Market Cap

44.8M

Sector

Energy

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$8.63

Market Cap

39.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLXE
XLO
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
39.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
KLXE
XLO
Price
$2.81
$8.63
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
291.4K
319.7K
Earning Date
03-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.79
EPS
N/A
N/A
Revenue
$636,600,000.00
$6,344,000.00
Revenue This Year
$3.89
$626.78
Revenue Next Year
$4.95
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.46
52 Week High
$3.74
$8.09

Technical Indicators

Market Signals
Indicator
KLXE
XLO
Relative Strength Index (RSI) 55.00 92.44
Support Level $1.59 $0.63
Resistance Level $3.09 N/A
Average True Range (ATR) 0.29 0.38
MACD -0.01 0.72
Stochastic Oscillator 57.44 97.01

Price Performance

Historical Comparison
KLXE
XLO

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: